Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Clinical and Translational Radiation Oncology|January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapyNikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Pediatric Blood & Cancer|May 4, 2026
Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective StudyJin-Ho Song, Jonathan Baron, Carlos Chavez Perez, et al.
Advances in Radiation Oncology|March 29, 2024
A Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and ChondrosarcomasSana S Dastgheyb, Alexandra D Dreyfuss, Michael J LaRiviere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal AdenocarcinomaZijian Yang, Michael J LaRiviere, Jina Ko, et al.
American Journal of Respiratory Cell and Molecular Biology|May 29, 2010
Simvastatin attenuates radiation-induced murine lung injury and dysregulated lung gene expressionBiji Mathew, Yong Huang, Jeffrey R Jacobson, et al.
International Journal of Radiation Oncology, Biology, Physics|May 25, 2020
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell LymphomaChristopher M Wright, Michael J LaRiviere, Jonathan A Baron, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 30, 2011
Role of sphingolipids in murine radiation-induced lung injury: protection by sphingosine 1-phosphate analogsBiji Mathew, Jeffrey R Jacobson, Evgeny Berdyshev, et al.
Prostate Cancer and Prostatic Diseases|October 3, 2020
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamideNaomi B Haas, Michael J LaRiviere, Thomas H Buckingham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung CancerCharu Aggarwal, Jeffrey C Thompson, Austin L Chien, et al.
Nature Microbiology|September 27, 2022
Computational identification of a systemic antibiotic for gram-negative bacteriaRyan D Miller, Akira Iinishi, Seyed Majed Modaresi, et al.
Pageof 7